FDA rolls back Juul marketing ban, reopening possibility of authorization

The FDA announced that it had formally withdrawn marketing denial orders issued to Juul Labs in 2022, providing the company with the opportunity to seek authorization for its e-cigarette sales.

Rescinding the marketing denial orders does not imply a new decision on authorizing e-cigarette sales; Juul's applications are now in 'pending status' for further review.

Juul expressed appreciation for the FDA's decision and aims to engage in a science- and evidence-based process for seeking marketing authorization for its products.

Read at Cbsnews